The Presence of Betapapillomavirus Antibodies around Transplantation Predicts the Development of Keratinocyte Carcinoma in Organ Transplant Recipients: A Cohort Study  Roel E. Genders, Hadi Mazlom, Angelika Michel, Elsemieke I. Plasmeijer, Koen D. Quint, Michael Pawlita, Els van der Meijden, Tim Waterboer, Hans de Fijter, Frans H. Claas, Ron Wolterbeek, Mariet C.W. Feltkamp, Jan Nico Bouwes Bavinck  Journal of Investigative Dermatology  Volume 135, Issue 5, Pages 1275-1282 (May 2015) DOI: 10.1038/jid.2014.456 Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Kaplan–Meier plot for development of keratinocyte carcinomas (KCs) in relation to human papillomavirus (HPV) serology. The cumulative incidence of keratinocyte carcinomas (KCs) is statistically significantly higher in organ transplant recipients (OTRs) who were seropositive against one or more HPV types of the Beta-papillomavirus (Beta-PV) genus between 1 year before and 1 year after the transplantation (P=0.043). Journal of Investigative Dermatology 2015 135, 1275-1282DOI: (10.1038/jid.2014.456) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions